VITA 34 International AG: VITA 34 International AG reporting record results both in storage and revenues. Results in line with expectations
VITA 34 International AG / Quarter Results Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Leipzig, 13 October 2008 - VITA 34 International AG (ISIN DE000A0BL849), the parent company of the leading private umbilical cord blood bank in the German-speaking countries VITA 34, posted record results for Q3 2008 both in stored units of umbilical cord blood and revenues. The number of stem cell preparations in the period under review increased to 2,976 after a record of 2,972 in the previous year’s period. In the first nine months of the current financial year storage increased from 7,968 to 8,282 units year-on-year. Revenues in Q3 reached a record value in the 10-year company history at EUR 4.1 million, beating the previous year’s period by EUR 29 k. At the end of the 9 month period aggregate revenues reached EUR 11.3 million compared to EUR 11.5 million in the previous year’s period. As a result of the scheduled increase in expenditure in line with the new marketing and sales strategy EBIT in Q3 was again negative as planned, reaching EUR -0.6 million. In the previous year EBIT amounted to EUR 0.1 million. In the first nine months of the year EBIT reached EUR -1.7 million compared to EUR 0.7 million in the prior year’s period. The group result in Q3 was recorded at EUR -0.5 million compared to EUR -0.2 million in the previous year’s period. In aggregate terms for the first nine months of 2008 the group result reached EUR -1.1 million after EUR 0.1 million in 2007. Liquid assets as of 30 September 2008 totalled EUR 7.2 million. VITA 34 therefore sees itself well positioned to break-even in the full financial year 2009 and is also confirming most recent forecasts issued for 2008. The full 9-month report is available for download in the investor relations section of www.vita34.de. Press contact / Investor Relations: Axel Mühlhaus / Dr. Sönke Knop edicto GmbH Zeißelstraße 19 D-60318 Frankfurt Tel. : +49 (069) 90550550 Fax : +49 (069) 90550577 E-mail: vita34@edicto.de 13.10.2008 Financial News transmitted by DGAP ---------------------------------------------------------------------- Language: English Issuer: VITA 34 International AG Deutscher Platz 5a 04103 Leipzig Deutschland Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: info@vita34.de Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------